When to suspect fungal infection in neonates: A clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase-negative staphylococcal bacteremia

Pediatrics

Volumn 106, Issue 4, 2000, Pages 712-718

  Benjamin, Daniel K ^a,b,c   Ross, Kelly ^a   McKinney Jr , Ross E ^a   Auten, Richard ^a   Fisher, Randall G ^a  

^a DUKE UNIVERSITY   (United States)

^b CLEMSON UNIVERSITY   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Albicans; Amphotericin; Candida; Central line; Cephalosporin; Neonate; Parapsilosis; Platelets; Sepsis; Staphylococcus epidermidis

Indexed keywords

AMPHOTERICIN B; AMPICILLIN; ANTIBIOTIC AGENT; CATECHOLAMINE; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; GENTAMICIN; STEROID; VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; BIRTH WEIGHT; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CENTRAL VENOUS CATHETER; CLINICAL FEATURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; DEATH; DIFFERENTIAL DIAGNOSIS; ENTERIC FEEDING; FUNGEMIA; GESTATIONAL AGE; HOSPITAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; NEWBORN; NEWBORN INFECTION; NEWBORN INTENSIVE CARE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0033772687     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.106.4.712     Document Type: Article

References (26)

1. Candida parapsilosis blood-stream infections is neonatal intensive care unit patients: Epidemiologic and laboratory confirmation of a common source outbreak
2. Neonatal Candida parapsilosis outbreak with a high case fatality rate
3. Emergence of Candida parapsilosis as the predominant species causing candidemia in children
4. Candidemia in a neonatal intensive care unit: Trends during fifteen years and clinical features of 111 cases
5. Invasive neonatal candidiasis: Comparison of albicans and parapsilosis infection
6. Candida parapsilosis: Epidemiology, pathogenecity, clinical manifestations, and antimicrobial susceptibility
7. Differential adhesion of pathogenic Candida species to epithelial and inert surfaces
8. Assesment of similarity among coagulase-negative staphylococci from sequential blood cultures of neonates and children by pulse-field gel electrophoresis
9. Characteristics of coagulase-negative staphylococci from infants with bacteremia
10. Staphylococcus epidermidis bacteremia in neonates: Further observations and the occurrence of focal infection
11. Surface colonization with coagulase-negative staphylococci in premature neonates
12. Risk factors associated with candidemia in the neonatal intensive care unit: A case-control study
13. Epidemiology of nosocomial fungal infections, with emphasis on Candida species
14. Late onset sepsis in very low birth weight neonates: A report from the National Institute of Child Health and Human Development Neonatal Research Network
15. Effect of extracellular substance from Staphylococcus epidermidis on the human cellular immune response
16. In situ management of confirmed central venous catheter-related bacteremia
17. Relative frequency of nosocomial pathogens at a university hospital during the decade 1980 to 1989
18. Outcome of treatment of candidemia in children whose central catheters were removed or retained
19. Candida: An increasingly important pathogen in the nursery
20. Staphylococcus epidermidis and other coagulase-negative staphylococci
21. Candidal mycetoma in the neonatal kidney
22. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia
23. Clinical use of amphotericin B and derivatives: Lore, mystique, and fact
24. Systemic candidiasis in very low-birth-weight infants (less than 1500 grams)
25. Assessment of antifungal therapy in an 800-gram infant with candidal arthritis and osteomyelitis
26. Disseminated fungal infections in very low-birth-weight infants: Therapeutic toxicity